SEPTInvestingStart Free

GNPX 8-K: SEC filing

Genprex

Filed with the SEC on · accession 0001437749-26-035077

GNPX filed a 8-K (current report) with the SEC on Nov 5, 2026. Genprex announced translational analysis results showing that its lead gene therapy candidate REQORSA (quaratusugene ozeplasmid) is associated with a systemic transcriptional shift toward cellular maintenance, repair, and quality control in lung cancer patients, presented at the GSA 2026 Annual… The stock moved -1.9% by the first close after the filing.

Summary of the filing

Genprex announced translational analysis results showing that its lead gene therapy candidate REQORSA (quaratusugene ozeplasmid) is associated with a systemic transcriptional shift toward cellular maintenance, repair, and quality control in lung cancer patients, presented at the GSA 2026 Annual Scientific Meeting.

For details, click here →How to read a 8-K →

Key details

RegistrantGenprex, Inc.
Research collaborator under sponsored research agreementMeharry Medical College

How GNPX stock reacted

Close before

$2.14

Nov 4, 2026

First close after

-1.87%

$2.10

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for GNPX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GNPX?

Click here

Frequently asked questions

What did GNPX file with the SEC on Nov 5, 2026?

GNPX filed a 8-K (SEC filing). Genprex announced translational analysis results showing that its lead gene therapy candidate REQORSA (quaratusugene ozeplasmid) is associated with a systemic transcriptional shift toward cellular maintenance, repair, and quality control in lung cancer patients, presented at the GSA 2026 Annual Scientific Meeting.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did GNPX stock react to this filing?

GNPX closed at $2.14 before the filing and $2.10 on Nov 5, 2026 (-1.87%).

Other GNPX SEC filings

Get alerts when GNPX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
GNPX overviewGNPX analysisGNPX newsLatest SEC filings